Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Inventory (2018 - 2025)

Historic Inventory for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $11.0 million.

  • Dna X's Inventory fell 1121.71% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 1121.71%. This contributed to the annual value of $10.6 million for FY2024, which is 6297.38% up from last year.
  • As of Q3 2025, Dna X's Inventory stood at $11.0 million, which was down 1121.71% from $9.9 million recorded in Q2 2025.
  • Over the past 5 years, Dna X's Inventory peaked at $12.4 million during Q3 2024, and registered a low of $3.4 million during Q2 2022.
  • Moreover, its 5-year median value for Inventory was $6.5 million (2023), whereas its average is $7.3 million.
  • As far as peak fluctuations go, Dna X's Inventory plummeted by 7126.78% in 2022, and later surged by 19329.22% in 2024.
  • Dna X's Inventory (Quarter) stood at $5.5 million in 2021, then decreased by 29.47% to $3.9 million in 2022, then soared by 66.68% to $6.5 million in 2023, then surged by 62.97% to $10.6 million in 2024, then grew by 3.44% to $11.0 million in 2025.
  • Its Inventory stands at $11.0 million for Q3 2025, versus $9.9 million for Q2 2025 and $8.6 million for Q1 2025.